Pathobiology of Helicobacter pylori infection.
Cave
D R
DR
St. Elizabeth's Medical Center, Boston, Massachusetts 02135, USA.
Goddard
P J
PJ
D000818:Animals; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D018450:Disease Progression; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000382:microbiology*; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism / Q000382:microbiology*; D005756:Gastritis / Q000382:microbiology* / Q000503:physiopathology; D016481:Helicobacter Infections / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology; D016480:Helicobacter pylori / Q000472:pathogenicity*; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D009853:Omeprazole